DEF 14AThe Ballot
Theravance Biopharma, Inc. files DEF 14A
Filed Mar 28, 2023 · 3y ago · Accession 0001104659-23-037712
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- DEF 14A
- Filing date
- Mar 28, 2023
- Report date
- —
- Document
- tm231836d4_def14a.htm
- Size
- 8.7 MB